DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Perceptive Advisors
Perceptive Advisors
Private equity with venture activity · probableNew York, NYperceptivelife.comSEC registered investment adviser
registered adviser; venture funds are 7% of 17 private funds
Importance
29
moderate
Active deployment
26
moderate
Emerging
0
low
Completeness
63
high
Freshness
100
high
Research priority
12
low
Identity and regulatory footprint
- Headquarters
- New York, NYadviserinfo.sec.gov
- Office address
- 51 ASTOR PLACE, 10TH FLR, New York, NY, 10003adviserinfo.sec.gov
- Business phone
- 646-205-5300adviserinfo.sec.gov
- SEC adviser type
- registered investment adviseradviserinfo.sec.gov
- SEC exemption claimed
- unknown
- Latest Form ADV
- Jul 13, 2026
- Private funds reported
- 17 (2 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $12Badviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Regulatory AUM
- $12Bthe adviser's RAUM, a regulatory measure, never a fund size
- Employees
- 49
- business email
- ir@perceptivelife.comperceptivelife.compublished by the subject
- business email
- patrick@perceptivelife.comperceptivelife.compublished by the subject
- business phone
- 646-205-5300adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
7 observed deals
Stated (the firm’s website)
- Sectors
- enterprise software, healthcare, biotech, medtech
- Stages
- not stated or not yet read
- Geography
- canada, global, japan, new york
- Check size
- not stated; DFX does not estimate checks from round sizes
- Self-described
- venture capital
Observed (from deals on record)
Stage at participation
series b 67%series d plus 33%
Stage at first entry
series b 67%series d plus 33%
Sectors
unknown 86%Biotechnology 14%
lead rate 33%follow-on rate 0%new logos, 12 months 7
Funds and vehicles
2 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Perceptive Xontogeny Venture Fund II, LP | Fund | 2018 form d first sale | Harvest | $508M Aug 8, 2024 | 181 | $169M of $200M | Nov 26, 2019 |
| Perceptive Xontogeny Venture Fund, LP | Fund | 2018 adv first reported | Harvest | $179M Aug 8, 2024 | 134 | unknown | unknown |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
4 current, 0 departed
Joseph Eric Edelman
PartnerChief Executive Officer And Portfolio Manager · since Dec 1, 2000
Alexander Rakitin
Platform and operationsChief Compliance Officer · since Oct 1, 2017
James Henry Mannix
Platform and operationsChief Operating Officer · since Dec 1, 2006
Peter William Fierro
Platform and operationsChief Financial Officer · since Jul 1, 2007
Investments on record
7 edges, 7 companies, 0 partner-attributed
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
13 relationships from shared deals, counted for the whole firm
Bioeconomy Capital GP, LLC 1 shared · one timeEli Lilly 1 shared · one timeCatalio Capital Management, LP 1 shared · one timeNVIDIA 1 shared · one timeInsight Venture Partners 1 shared · one timeBVF Partners 1 shared · one time · they led 1Life Sciences 1 shared · one time · they led 1Life Sciences 1 shared · one time · they led 1Kalehua Capital 1 shared · one timeOmega Funds 1 shared · one timeOmega Funds 1 shared · one timeLife Sciences 1 shared · one timeSofina 1 shared · one time · we led 1
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
4 dated events
- Mar 30, 2021Perceptive Xontogeny Venture Fund II, LP first reported on Form ADV by Perceptive Advisors (Venture Capital Fund)Fund first reported on Form ADVFundsFactPerceptive Xontogeny Venture Fund II, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Aug 30, 2018Perceptive Xontogeny Venture Fund, LP first reported on Form ADV by Perceptive Advisors (Private Equity Fund)Fund first reported on Form ADVFundsFactPerceptive Xontogeny Venture Fund, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Oct 1, 2017Alexander Rakitin joined Schedule A of Perceptive Advisors as Chief Compliance Officer
- Mar 30, 2012Perceptive Advisors first filed Form ADV (IA)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Private equity with venture activity (probable, 75%, cls-1)registered adviser; venture funds are 7% of 17 private funds
- Sep 12, 2026Private equity with venture activity (probable, 75%, cls-1)registered adviser; venture funds are 7% of 20 private funds
Evidence
73 observations from 3 sources